For: | Li WD, Fu KF, Li GM, Lian YS, Ren AM, Chen YJ, Xia JR. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus. World J Gastroenterol 2015; 21(32): 9607-9613 [PMID: 26327768 DOI: 10.3748/wjg.v21.i32.9607] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v21/i32/9607.htm |
Number | Citing Articles |
1 |
Youngji Han, Young Chul Shin, Ae-Hyang Kim, Eun-Young Kwon, Myung-Sook Choi. Evaluation of the Dose-Dependent Effects of Fermented Mixed Grain Enzyme Food on Adiposity and Its Metabolic Disorders in High-Fat Diet-Induced Obese Mice. Journal of Medicinal Food 2021; 24(8): 873 doi: 10.1089/jmf.2021.K.0070
|
2 |
Sandrine Barbois, Catherine Arvieux, Vincent Leroy, Fabian Reche, Nathalie Stürm, Anne-Laure Borel. Benefit–risk of intraoperative liver biopsy during bariatric surgery: review and perspectives. Surgery for Obesity and Related Diseases 2017; 13(10): 1780 doi: 10.1016/j.soard.2017.07.032
|
3 |
Fiona Bragg, Kun Tang, Yu Guo, Andri Iona, Huaidong Du, Michael V. Holmes, Zheng Bian, Christiana Kartsonaki, Yiping Chen, Ling Yang, Qiang Sun, Caixia Dong, Junshi Chen, Rory Collins, Richard Peto, Liming Li, Zhengming Chen. Associations of General and Central Adiposity With Incident Diabetes in Chinese Men and Women. Diabetes Care 2018; 41(3): 494 doi: 10.2337/dc17-1852
|
4 |
Stefan Kabisch, Nina M. T. Meyer, Caroline Honsek, Margrit Kemper, Christiana Gerbracht, Ayman M. Arafat, Ulrike Dambeck, Martin A. Osterhoff, Martin O. Weickert, Andreas F. H. Pfeiffer. Predicting Factors for Metabolic Non-Response to a Complex Lifestyle Intervention—A Replication Analysis to a Randomized-Controlled Trial. Nutrients 2022; 14(22): 4721 doi: 10.3390/nu14224721
|
5 |
Luca Valenti, Elisabetta Bugianesi, Utpal Pajvani, Giovanni Targher. Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?. Liver International 2016; 36(11): 1563 doi: 10.1111/liv.13185
|
6 |
P. Di Bonito, L. Pacifico, C. Chiesa, G. Valerio, E. Miraglia del Giudice, C. Maffeis, A. Morandi, C. Invitti, M. R. Licenziati, S. Loche, G. Tornese, F. Franco, M. Manco, M. G. Baroni. Impaired fasting glucose and impaired glucose tolerance in children and adolescents with overweight/obesity. Journal of Endocrinological Investigation 2017; 40(4): 409 doi: 10.1007/s40618-016-0576-8
|
7 |
Michael H. Le, Yee Hui Yeo, Xiaohe Li, Jie Li, Biyao Zou, Yuankai Wu, Qing Ye, Daniel Q. Huang, Changqing Zhao, Jie Zhang, Chenxi Liu, Na Chang, Feng Xing, Shiping Yan, Zi Hui Wan, Natasha Sook Yee Tang, Maeda Mayumi, Xinting Liu, Chuanli Liu, Fajuan Rui, Hongli Yang, Yao Yang, Ruichun Jin, Richard H.X. Le, Yayun Xu, David M. Le, Scott Barnett, Christopher Donald Stave, Ramsey Cheung, Qiang Zhu, Mindie H. Nguyen. 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2022; 20(12): 2809 doi: 10.1016/j.cgh.2021.12.002
|
8 |
Kai En Chan, Elden Yen Hng Ong, Charlotte Hui Chung, Christen En Ya Ong, Benjamin Koh, Darren Jun Hao Tan, Wen Hui Lim, Jie Ning Yong, Jieling Xiao, Zhen Yu Wong, Nicholas Syn, Apichat Kaewdech, Margaret Teng, Jiong-Wei Wang, Nicholas Chew, Dan Yock Young, Alfred Know, Mohammad Shadab Siddiqui, Daniel Q. Huang, Nobuharu Tamaki, Vincent Wai-Sun Wong, Christos S. Mantzoros, Arun Sanyal, Mazen Noureddin, Cheng Han Ng, Mark Muthiah. Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies. Clinical Gastroenterology and Hepatology 2024; 22(3): 488 doi: 10.1016/j.cgh.2023.09.018
|
9 |
Frank T. Spradley, Jillian A. Smith, Barbara T. Alexander, Christopher D. Anderson. Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease. American Journal of Physiology-Endocrinology and Metabolism 2018; 315(5): E795 doi: 10.1152/ajpendo.00394.2017
|
10 |
Sean Chun-Chang Chen, Shan Pou Tsai, Jing-Yun Jhao, Wun-Kai Jiang, Chwen Keng Tsao, Ly-Yun Chang. Liver Fat, Hepatic Enzymes, Alkaline Phosphatase and the Risk of Incident Type 2 Diabetes: A Prospective Study of 132,377 Adults. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-04631-7
|
11 |
Lars H. Breimer, Dimitri P. Mikhailidis. Does bilirubin protect against developing diabetes mellitus?. Journal of Diabetes and its Complications 2016; 30(4): 728 doi: 10.1016/j.jdiacomp.2016.01.019
|
12 |
Hui Zhao, Bin Hu. Risk Factors for Non-alcoholic Fatty Liver Disease in Chinese Population: A Five-year Follow-up Study. Iranian Red Crescent Medical Journal 2019; 21(7) doi: 10.5812/ircmj.91064
|
13 |
Yang Xia, Limin Cao, Qing Zhang, Li Liu, Shunming Zhang, Ge Meng, Hongmei Wu, Yeqing Gu, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Kun Song, Qijun Wu, Kaijun Niu, Yuhong Zhao. Adherence to a vegetable dietary pattern attenuates the risk of non‐alcoholic fatty liver disease in incident type 2 diabetes: The TCLSIH cohort study. Journal of Internal Medicine 2022; 291(4): 469 doi: 10.1111/joim.13428
|
14 |
Emily C. Peters, Luke Safayan, Tyler J. Marx, Emily Ngu, Anastasiia Vasileva, India Zappia, William H. Powell, Frank A. Duca, Jennifer H. Stern. Metabolic and physical function are improved with lifelong 15% calorie restriction in aging male mice. Biogerontology 2022; 23(6): 741 doi: 10.1007/s10522-022-09996-5
|
15 |
Behnam Rabiee, Farzin Roozafzai, Gholam Reza Hemasi, Hossein Poustchi, Hossein Keyvani, Mahmood Reza Khonsari, Hossein Ajdarkosh, Mansooreh Maadi, Fatemeh Sima Saeedian, Farhad Zamani. The Prevalence of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus in an Iranian Population. Middle East Journal of Digestive Diseases 2017; 9(2): 86 doi: 10.15171/mejdd.2017.56
|
16 |
Limin Cao, Yu An, Huiyuan Liu, Jinguo Jiang, Wenqi Liu, Yuhan Zhou, Mengyuan Shi, Wei Dai, Yanling Lv, Yuhong Zhao, Yanhui Lu, Liangkai Chen, Yang Xia. Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis. BMC Medicine 2024; 22(1) doi: 10.1186/s12916-024-03315-0
|
17 |
Stefania Kiapidou, Christina Liava, Maria Kalogirou, Evangelos Akriviadis, Emmanouil Sinakos. Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?. Annals of Hepatology 2020; 19(2): 134 doi: 10.1016/j.aohep.2019.07.013
|
18 |
Hong-jie Yu, Mandy Ho, Xiangxiang Liu, Jundi Yang, Pui Hing Chau, Daniel Yee Tak Fong. Association of weight status and the risks of diabetes in adults: a systematic review and meta-analysis of prospective cohort studies. International Journal of Obesity 2022; 46(6): 1101 doi: 10.1038/s41366-022-01096-1
|
19 |
Li Ang, Liu Yuguang, Wang Liying, Zhang Shuying, Xu Liting, Wang Shumin. Ergosterol Alleviates Kidney Injury in Streptozotocin-Induced Diabetic Mice. Evidence-Based Complementary and Alternative Medicine 2015; 2015: 1 doi: 10.1155/2015/691594
|
20 |
Hong-jie Yu, Mandy Ho, Xiangxiang Liu, Jundi Yang, Pui Hing Chau, Daniel Yee Tak Fong. Incidence and temporal trends in type 2 diabetes by weight status: A systematic review and meta-analysis of prospective cohort studies. Journal of Global Health 2023; 13 doi: 10.7189/jogh.13.04088
|
21 |
Bong Jin Ko, Young Seok Kim, Sang Gyune Kim, Jung Hwan Park, Sae Hwan Lee, Soung Won Jeong, Jae Young Jang, Hong Soo Kim, Boo Sung Kim, Sun Mi Kim, Young Don Kim, Gab Jin Cheon, Bo Ra Lee. Relationship between 25-Hydroxyvitamin D Levels and Liver Fibrosis as Assessed by Transient Elastography in Patients with Chronic Liver Disease. Gut and Liver 2016; 10(5): 818 doi: 10.5009/gnl15331
|
22 |
Alessandro Mantovani, Christopher D. Byrne, Enzo Bonora, Giovanni Targher. Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis. Diabetes Care 2018; 41(2): 372 doi: 10.2337/dc17-1902
|
23 |
Stavra A. Xanthakos. Nonalcoholic Steatohepatitis in Children. Clinics in Liver Disease 2022; 26(3): 439 doi: 10.1016/j.cld.2022.05.001
|
24 |
Soon Sun Kim, Hyo Jung Cho, Hyun Ji Kim, Dae Ryong Kang, Jacob R. Berry, Jin Hong Kim, Min Jae Yang, Sun Gyo Lim, SooJin Kim, Jae Youn Cheong, Sung Won Cho. Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects. Digestive and Liver Disease 2018; 50(4): 370 doi: 10.1016/j.dld.2017.12.018
|
25 |
Kseniya Yu. Vlasova, Petr Ostroverkhov, Daria Vedenyapina, Tamara Yakimova, Alla Trusova, Galina Yurievna Lomakina, Stepan Sergeevich Vodopyanov, Mikhail Grin, Natalia Klyachko, Vladimir Chekhonin, Maxim Abakumov. Liposomal Form of 2,4-Dinitrophenol Lipophilic Derivatives as a Promising Therapeutic Agent for ATP Synthesis Inhibition. Nanomaterials 2022; 12(13): 2162 doi: 10.3390/nano12132162
|
26 |
Abd Elkhalek Hamed, Nadia Elwan, Mervat Naguib, Reda Elwakil, Gamal Esmat, Mohamed El Kassas, Sherief Abd-Elsalam, Shorouk Moussa. Diabetes Association with Liver Diseases: An Overview for Clinicians. Endocrine, Metabolic & Immune Disorders - Drug Targets 2019; 19(3): 274 doi: 10.2174/1871530318666181116111945
|
27 |
Shengju Wang, Baochao Cai, Xuke Han, Yang Gao, Xiaoran Zhang, Ruili Wang, Yuan Zhang, Qiu Chen. Vitamin D supplementation for nonalcoholic fatty liver disease in type 2 diabetes mellitus. Medicine 2020; 99(19): e20148 doi: 10.1097/MD.0000000000020148
|
28 |
V. Iriarte-Campo, C. de Burgos-Lunar, J. Mostaza, C. Lahoz, J. Cárdenas-Valladolid, P. Gómez-Campelo, B. Taulero-Escalera, F.J. San-Andrés-Rebollo, F. Rodriguez-Artalejo, M.A. Salinero-Fort. Incidence of T2DM and the role of baseline glycaemic status as a determinant in a metropolitan population in northern Madrid (Spain). Diabetes Research and Clinical Practice 2024; 209: 111119 doi: 10.1016/j.diabres.2024.111119
|
29 |
Rui Mao, Fan Yang, Yu Zhang, Hongtao Liu, Pengsen Guo, Yanjun Liu, Tongtong Zhang. High expression of CD52 in adipocytes: a potential therapeutic target for obesity with type 2 diabetes. Aging 2021; 13(8): 11043 doi: 10.18632/aging.202714
|
30 |
Abd Elkhalek Hamed, Medhat Elsahar, Nadia M. Elwan, Sarah El-Nakeep, Mervat Naguib, Hanan Hamed Soliman, Ashraf Ahmed Aboubakr, Amany AbdelMaqsod, Heba Sedrak, Samir N. Assaad, Reda Elwakil, Gamal Esmat, Samira Salh, Taymour Mostafa, Sherif Mogawer, Sameh Emil Sadek, Maha M. Saber, Hanan Ezelarab, Asem Ashraf Mahmoud, Souad Sultan, Mohamed El Kassas, Ehab Kamal, Naglaa M. ElSayed, Shorouk moussa. Managing diabetes and liver disease association. Arab Journal of Gastroenterology 2018; 19(4): 166 doi: 10.1016/j.ajg.2018.08.003
|
31 |
Jiang Deng, Zhiyi Han, Hailing Tang, Cong Yao, Xiaoling Li, Jingyuan Xu, Mimi Zhou, Xin Xing, Fangxiong Wu, Jianning Li, Xiaolan Lu, Haitao Shi. Elevated fasting glucose level increases the risk of fatty liver disease: a 10-year study of 31,154 individuals. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02615-0
|
32 |
Chen-Yuan Chiu, Tien-Chia Chang, Shing-Hwa Liu, Meng-Tsan Chiang. The regulatory effects of fish oil and chitosan on hepatic lipogenic signals in high-fat diet-induced obese rats. Journal of Food and Drug Analysis 2017; 25(4): 919 doi: 10.1016/j.jfda.2016.11.015
|
33 |
Miao Liu, Jianhua Wang, Jing Zeng, Xiutang Cao, Yao He. Association of NAFLD With Diabetes and the Impact of BMI Changes: A 5-Year Cohort Study Based on 18,507 Elderly. The Journal of Clinical Endocrinology & Metabolism 2017; 102(4): 1309 doi: 10.1210/jc.2016-3440
|
34 |
René Rodríguez-Gutiérrez, Alejandro Salcido-Montenegro, José Gerardo González-González. Early Clinical Expressions of Insulin Resistance: The Real Enemy to Look For. Diabetes Therapy 2018; 9(1): 435 doi: 10.1007/s13300-017-0348-2
|
35 |
Li-Peng Jiang, Hong-Zhi Sun. Long-chain saturated fatty acids and its interaction with insulin resistance and the risk of nonalcoholic fatty liver disease in type 2 diabetes in Chinese. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1051807
|
36 |
L. Barana, A. Nelva, P. Scivetti, M. Costanzo, C. G. Fanelli. Diagnosis of hepatic steatosis and steatohepatitis in people with new-onset type 2 diabetes: a multidisciplinary approach. Endocrine 2024; 84(2): 412 doi: 10.1007/s12020-024-03715-5
|
37 |
Anne-Sophie R. Stroes, Miriam Vos, Marc A. Benninga, Bart G. P. Koot. Pediatric MASLD: current understanding and practical approach. European Journal of Pediatrics 2024; 184(1) doi: 10.1007/s00431-024-05848-1
|
38 |
Muni Swamy Ganjayi, Balaji Meriga, Balaji Hari, Lokanatha Oruganti, Sreenivasulu Dasari, Ramgopal Mopuri. PolyPhenolic rich fraction of Terminalia paniculata attenuates obesity through inhibition of pancreatic amylase, lipase and 3T3-L1 adipocyte differentiation. Journal of Nutrition & Intermediary Metabolism 2017; 10: 19 doi: 10.1016/j.jnim.2017.11.003
|
39 |
Yuting Gao, Tianyi Zhao, Shuoning Song, Yanbei Duo, Junxiang Gao, Tao Yuan, Weigang Zhao. Lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes mellitus: A literature review and meta-analysis. Diabetes Research and Clinical Practice 2023; 200: 110699 doi: 10.1016/j.diabres.2023.110699
|
40 |
Aki Juhani Käräjämäki, Risto Bloigu, Heikki Kauma, Y. Antero Kesäniemi, Olli-Pekka Koivurova, Juha Perkiömäki, Heikki Huikuri, Olavi Ukkola. Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes. Metabolism 2017; 66: 55 doi: 10.1016/j.metabol.2016.06.009
|
41 |
G. Targher, G. Marchesini, C.D. Byrne. Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: Causal association or epiphenomenon?. Diabetes & Metabolism 2016; 42(3): 142 doi: 10.1016/j.diabet.2016.04.002
|
42 |
Z. Li, F. Sun, Z. Hu, J. Xiang, J. Zhou, S. Yan, J. Wu, L. Zhou, S. Zheng. New-Onset Diabetes Mellitus in Liver Transplant Recipients With Hepatitis C: Analysis of the National Database. Transplantation Proceedings 2016; 48(1): 138 doi: 10.1016/j.transproceed.2015.11.010
|